Items | All | NF group | n | Control group | n | p |
---|---|---|---|---|---|---|
 Number of patient | 54 | 28 | 28 | 26 | 26 |  |
 Sex (male/female) | 36/18 | 17/11 | 28 | 19/7 | 26 | n.s.a |
 Age (years) | 76.4 ± 5.0 (70.0–87.0) | 77.1 ± 4.8 (70.0–87.0) | 28 | 75.6 ± 5.0 (70.0–87.0) | 26 | n.s.b |
 Dialysis vintage (years) | 8.3 ± 6.2 (0.5–30.0) | 9.8 ± 7.4 (0.5–30.0) | 28 | 6.8 ± 4.2 (1.0–15.0) | 26 | n.s.c |
 Dry weight (kg) | 52.5 ± 9.8 (33.8–90.0) | 50.8 ± 8.8 (33.8–67.8) | 28 | 54.3 ± 10.6 (34.5–90.0) | 26 | n.s. b |
 Albumin concentration before dialysis (g/dL) | 3.6 ± 0.3 (3.0–4.4) | 3.6 ± 0.3 (3.1–4.0) | 27 | 3.6 ± 0.3 (3.0–4.4) | 25 | n.s. b |
Dialysis condition | ||||||
 Blood flow rate (mL/min) | 219.3 ± 30.3 (150–300) | 218.9 ± 32.7 (150–300) | 28 | 219.6 ± 28.2 (150–250) | 26 | n.s. b |
 Dialysis time (h) | 4.0 ± 0.4 (3.0–5.0) | 4.0 ± 0.4 (3.0–5.0) | 28 | 4.0 ± 0.3 (3.0–5.0) | 26 | n.s. b |
 Effective surface area (m2) | 1.7 ± 0.3 (1.3–2.1) | 1.7 ± 0.3 (1.3–2.1) | 28 | 1.7 ± 0.3 (1.4–2.1) | 26 | n.s. b |
 Dialysis membrane (PS/PES/PEPA) | (32/12/10) | (13/8/7) | 28 | (19/4/3) | 26 | n.s. a |
 Classification of dialyzer# (I·II/III/IV/V) | (0/6/26/22) | (0/1/16/11) | 28 | (0/5/10/11) | 26 | n.s. a |
 Dialysate (with acetate/without acetate) | (44/10) | (20/8) | 28 | (24/2) | 26 | p < 0.05 a |
Medical history | ||||||
 Diabetes mellitus (Y/N) | (18/36) | (9/19) | 28 | (9/17) | 26 | n.s. a |
 Cerebrocardiovascular event (Y/N) | (12/42) | (7/21) | 28 | (5/21) | 26 | n.s. a |